¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"mutation rate"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
loss-of-function mutation
±â´É¼Ò½Çµ¹¿¬º¯ÀÌ
missense mutation
°ú¿Àµ¹¿¬º¯ÀÌ, ¹Ì½º¼¾½ºµ¹¿¬º¯ÀÌ
mutation
µ¹¿¬º¯ÀÌ
mutation genetics
º¯ÀÌÀ¯ÀüÇÐ
natural mutation
ÀÚ¿¬µ¹¿¬º¯ÀÌ
nonsense mutation
¹«Àǹ̵¹¿¬º¯ÀÌ, ³Í¼¾½ºµ¹¿¬º¯ÀÌ
plaque morphology mutation
ÆÇÇüŵ¹¿¬º¯ÀÌ, ÇöóÅ©Çüŵ¹¿¬º¯ÀÌ
point mutation
Á¡µ¹¿¬º¯ÀÌ
polar mutation
±Ø¼ºµ¹¿¬º¯ÀÌ
population mutation
Áý´Üµ¹¿¬º¯ÀÌ
recessive mutation
¿¼ºµ¹¿¬º¯ÀÌ
reverse mutation
¿ªµ¹¿¬º¯ÀÌ, º¹±Íµ¹¿¬º¯ÀÌ
somatic mutation
ü¼¼Æ÷µ¹¿¬º¯ÀÌ
somatic mutation theory
ü¼¼Æ÷µ¹¿¬º¯À̼³
spontaneous mutation
ÀÚ¿¬µ¹¿¬º¯ÀÌ
ÀÌÀü
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
case fatality rate
Ä¡¸í·ü
case morbidity rate
Áõ·ÊÀÌȯÀ²
crude birth rate
ÀϹÝÃâ»ý·ü, Á¶Ãâ»ý·ü
crude death rate
ÀϹݻç¸Á·ü, Á¶»ç¸Á·ü
erythrocyte sedimentation rate
ÀûÇ÷±¸Ä§°¼Óµµ, Ç÷ħ¼Óµµ
fatality rate
Ä¡¸í·ü
fertility rate
»ý½Ä·ü, ¼öÅÂÀ²
fetal death rate
žƻç¸Á·ü
fetal heart rate
žƽɹڼö
five-year survival rate
¿À³â»ýÁ¸·ü
glomerular filtration rate
Å丮¿©°úÀ², »ç±¸Ã¼¿©°úÀ²
heart rate
½ÉÀå¹Úµ¿¼ö
infant mortality rate
¿µ¾Æ»ç¸Á·ü
morbidity rate
ÀÌȯ·ü
mortality rate
»ç¸Á·ü
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
induced mutation
À¯¹ßµ¹¿¬º¯ÀÌ
loss mutation
»ó½Çµ¹¿¬º¯ÀÌ
mutation
µ¹¿¬º¯ÀÌ
missense mutation
°ú¿Àµ¹¿¬º¯ÀÌ
multiple allelic mutation
¹µ¸Â¼¶µ¹¿¬º¯ÀÌ
natural mutation
ÀÚ¿¬µ¹¿¬º¯ÀÌ
nonsense mutation
¹«Àǹ̵¹¿¬º¯ÀÌ
plaque morphology mutation
(¢¡plaque-type mutation) ÇöóÅ©Çüµ¹¿¬º¯ÀÌ
plaque-type mutation
ÇöóÅ©Çüµ¹¿¬º¯ÀÌ
point mutation
Á¡µ¹¿¬º¯ÀÌ
polar mutation
±Ø¼ºµ¹¿¬º¯ÀÌ
population mutation
Áý´Ü±ºµ¹¿¬º¯ÀÌ
reading frame mutation
ÇØµ¶Æ²µ¹¿¬º¯ÀÌ
recessive mutation
¿¼ºµ¹¿¬º¯ÀÌ
reverse mutation
¿ªµ¹¿¬º¯ÀÌ, º¹±Íµ¹¿¬º¯ÀÌ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
GFR= glomerular filtration rate
»ç±¸Ã¼°Å¸§·ü.
Heart rate
½É¹Ú¼ö(ãýÚÑâ¦)
MVR=£¾maximus voiding rate
ÃÖ´ë¹è´¢À².
Westergren sedimentation rate
¿þ½ºÅͱ׷»Ä§°¼Óµµ
absorbed dose rate
Èí¼ö¼±·®À²
actual death rate
½ÇÁ¦»ç¸Á·ü(ËàÌ¡Ë×ËÎËô).
adjusted death rate
Á¶Á¤»ç¸Á·ü.
age specific death rate
¿¬·Éº° »ç¸Á·ü
air kerma-rate constant
°ø±âÄ¿¸¶À²»ó¼ö
alveolar ventilation rate
ÆóÆ÷ȯ±âºñ(¡üµÑ¨Ýï)
arterial perfusion rate
µ¿¸Æ°ü·ùÀ²
fractional fibrinogen catabolic rate
ºÐȹº° ¼¶À¯¼Ò¿ø ´ë»çÀ².
frame rate
ȸéÀ²
frame rate
È¸é ¹ß»ýÀ² (ûþØü Û¡ßæëÒ)
general fertility rate
ÀϹÝÃâ»êÀ².
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
gene mutation
À¯ÀüÀÚµ¹¿¬º¯ÀÌ.
gene mutation
À¯ÀüÀÚµ¹¿¬º¯ÀÌ.
gene mutation
À¯ÀüÀÚ(µ¹¿¬)º¯ÀÌ
genetic mutation
À¯ÀüÀû µ¹¿¬º¯ÀÌ
genomic mutation
À¯ÀüÀÚµ¹¿¬º¯ÀÌ
host range mutation
¼÷ÁÖ¿ªº¯ÀÌ
induced mutation
À¯¹ß¼º µ¹¿¬º¯ÀÌ.
induced mutation
À¯¹ßµ¹¿¬º¯ÀÌ
lethal mutation
Ä¡»çµ¹¿¬º¯ÀÌ(¡ÔÍæ×ܨì¶).
lethal mutation
Ä¡»ç µ¹¿¬º¯ÀÌ
loss mutation
»ó½Çµ¹¿¬º¯ÀÌ(ßÃã÷ÔÍæÔܨì¶).
missense mutation
°ú¿Àµ¹¿¬º¯ÀÌ(Φè¦ÔÍæÔܨì¶).
multiple allelic mutation
º¹´ë¸³ÇüÁúº¯ÀÌ(ÜÜÓßí¡û¡òõܨì¶).
mutation
(µ¹¿¬)º¯ÀÌ(ÔÍæÔܨì¶)
mutation detection
(µ¹¿¬)º¯À̰ËÃâ
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½